Editors
Veronika Ballová
Národný Onkologický Ústav, Bratislava, Slovak Republic
Mariano Provencio Pulla
Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
Contributors
Chapter 1: Cancer Treatment during Pregnancy
Azim H.A. Jr. Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Peccatori F.A. Division of Gynecologic Oncology, Fertility and Procreation Unit, European Institute of Oncology, Milan, Italy
Chapter 2: Cancer Treatment in Patients with Renal Insufficiency
Peyrade F. Department of Hemato-oncology, Centre Régional de Lutte Contre le Cancer, Nice, France
Thyss A. Department of Hemato-oncology, Centre Régional de Lutte Contre le Cancer, Nice, France
Chapter 3: Cancer Treatment in Patients with Hepatic Dysfunction
Joerger M. Department of Medical Oncology & Hematology, Cantonal Hospital, St. Gallen, Switzerland
Beumer J.H. University of Pittsburgh Cancer Institute and Department of Pharmaceutical Sciences, University of Pittsburgh, Pennsylvania, USA
Chapter 4: Cancer Treatment in Solid Organ Transplant Recipients
Venugopal B. Beatson West of Scotland Cancer Centre, Glasgow, UK
Wilson C. Beatson West of Scotland Cancer Centre, Glasgow, UK
Parker A. Beatson West of Scotland Cancer Centre, Glasgow, UK
Chapter 5: Cancer Treatment in Patients with HIV
Spina M. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy
Bearz A. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy
Berretta M. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy
Vaccher E. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy
Tirelli U. Division of Medical Oncology A, National Cancer Institute, Aviano (PN), Italy
Chapter 6: Cancer Treatment in Patients with Hepatitis
de la Revilla J. Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Calleja J.L. Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Abreu L. Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Chapter 7: Cancer Treatment in Patients with Diabetes
Mateo J. The Royal Marsden NHS Foundation Trust, Sutton, UK
Castro E. Spanish National Cancer Research Centre, Madrid, Spain
Olmos D. Spanish National Cancer Research Centre, Madrid, Spain
Chapter 8: Cancer Treatment in Patients with Heart Disease
Curigliano G. Department of Medicine, Division of Early Drug Development, European Institute of Oncology, Milan, Italy
Mandala M. Unit of Clinical and Translational Research, Department of Oncology and Haematology, Division of Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy
Cipolla C.M. Division of Cardiology, European Institute of Oncology, Milan, Italy
Chapter 9: Cancer Treatment in Patients with Religious Constraints
Plana J. Borja Institute of Bioethics, Ramon Llull University, Barcelona, Spain
Terribas N. Borja Institute of Bioethics, Ramon Llull University, Barcelona, Spain
Chapter 10: Cancer Treatment in Patients Unable to Consent
Jovell A.J. Universitat Internacional de Catalunya, Sant Cugat del Vallés, Spain
Navarro M.D. Universitat Internacional de Catalunya, Sant Cugat del Vallés, Spain
Declaration of Interest:
Chapter 1: Dr Azim Jr and Dr Peccatori have reported no conflicts of interest.
Chapter 2: Dr Peyrade has reported that he is on the board of Merck. Dr Thyss has reported no conflicts of interest.
Chapter 3: Dr Joerger has reported no conflicts of interest. Dr Beumer reported that he receives research funding from Spectrum, BMS and Novartis, and that his wife is an employee of GlaxoSmithKline.
Chapter 4: Dr Venugopal, Dr Wilson and Dr Parker have reported no conflicts of interest.
Chapter 5: Dr Spina, Dr Bearz, Dr Berretta, Dr Vaccher, and Dr Tirelli have reported no conflicts of interest.
Chapter 6: Dr de la Revilla, Dr Calleja, and Dr Abreu have reported no conflicts of interest.
Chapter 7: Dr Mateo, Dr Castro, and Dr Olmos have reported no conflicts of interest.
Chapter 8: Dr Curigliano, Professor Mandala, and Dr Cipolla have reported no conflicts of interest.
Chapter 9: Dr Plana, and Dr Terribas have reported no conflicts of interest.
Chapter 10: Dr Jovell has an academic position and is not involved in the prescription of any medical tests or therapies, nor sits on any committees involved in the regulation of drugs or procedures. Dr Navarro has an academic position and is not involved in the prescription of any medical tests or therapies, nor sits on any committees involved in the regulation of drugs or procedures.
